Adrenoleukodystrophy.
Engelen M, Kemp S, Eichler F.
Handb Clin Neurol. 2024;204:133-138. doi: 10.1016/B978-0-323-99209-1.00022-3.
Cholesterol transport through lysosome-peroxisome membrane contacts.
Chu BB, Liao YC, Qi W, Xie C, Du X, Wang J, Yang H, Miao HH, Li BL, Song BL.
Cell. 2015 Apr 9;161(2):291-306. doi: 10.1016/j.cell.2015.02.019.
X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies.
Turk BR, Theda C, Fatemi A, Moser AB.
Int J Dev Neurosci. 2020 Feb;80(1):52-72. doi: 10.1002/jdn.10003. Epub 2020 Jan 26.
An update on the diagnosis and treatment of adrenoleukodystrophy.
Gujral J, Sethuram S.
Curr Opin Endocrinol Diabetes Obes. 2023 Feb 1;30(1):44-51. doi: 10.1097/MED.0000000000000782. Epub 2022 Nov 14.
International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based Approach.
Engelen M, van Ballegoij WJC, Mallack EJ, Van Haren KP, Köhler W, Salsano E, van Trotsenburg ASP, Mochel F, Sevin C, Regelmann MO, Tritos NA, Halper A, Lachmann RH, Davison J, Raymond GV, Lund TC, Orchard PJ, Kuehl JS, Lindemans CA, Caruso P, Turk BR, Moser AB, Vaz FM, Ferdinandusse S, Kemp S, Fatemi A, Eichler FS, Huffnagel IC.
Neurology. 2022 Nov 22;99(21):940-951. doi: 10.1212/WNL.0000000000201374. Epub 2022 Sep 29.
[Addison-Schilder's disease].
Higashimori K, Ogihara T.
Ryoikibetsu Shokogun Shirizu. 1993;(1):387-9.
Peroxisomal leukodystrophy.
Engelen M.
Handb Clin Neurol. 2024;204:139-145. doi: 10.1016/B978-0-323-99209-1.00021-1.
Peroxisomal disorders.
Aubourg P, Wanders R.
Handb Clin Neurol. 2013;113:1593-609. doi: 10.1016/B978-0-444-59565-2.00028-9.
[Peroxisomal disorders].
Stradomska TJ.
Postepy Biochem. 2018 Dec 29;64(4):359-367. doi: 10.18388/pb.2018_150.
Adrenoleukodystrophy.
Moser HW, Bergin A, Naidu S, Ladenson PW.
Endocrinol Metab Clin North Am. 1991 Jun;20(2):297-318.
